{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-265510","form_type":"8-K","ticker":"CTKB","cik":"0001831915","company_name":"Cytek Biosciences, Inc.","filed_at":"2021-09-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:19.955792+00:00","generated_at":"2026-06-29T05:54:07.930482+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Cytek Biosciences Q2 revenue $30.4M (+59% YoY); operating income turns positive at $3.8M","bullets":["Revenue $30.4M, +59% YoY; gross margin improved to 65% from 43%.","Operating income $3.8M vs. ($0.2M) a year ago; net income $2.7M down from $8.1M.","Installed base reached 855 instruments, with 104 placements in Q2.","Launched Aurora Cell Sorter and Automated Sample Loader during the quarter.","Completed IPO in July 2021, raising $215M in net proceeds to strengthen balance sheet."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-265510","json":"https://secwatch.observer/filing/0001193125-21-265510.json","markdown":"https://secwatch.observer/filing/0001193125-21-265510.md","text":"https://secwatch.observer/filing/0001193125-21-265510.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831915/000119312521265510/0001193125-21-265510-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831915/000119312521265510/d187138d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T05:54:07.930482+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}